title: Factors that influence patient response to requests to change to a unified restrictive formulary.
abstract: OBJECTIVE
  To determine factors that influence patient willingness to accept a medication change to a unified, restrictive formulary.
  
  
  METHODS
  Prospective cohort study.
  
  
  METHODS
  University-affiliated hospital-based primary care internal medicine practice.
  
  
  METHODS
  Two hundred ninety-seven members of a managed care plan who had received a prescription for a nonformulary medication in the previous 4 months and whose primary care physician approved a conversion to a formulary medication.
  
  
  METHODS
  Clinical nurses invited patients to change to a formulary medication at the time of a telephone refill request based on a standard script.
  
  
  RESULTS
  The overall conversion rate to the formulary medication was 59.8%. Seventy-four percent of patients who requested a refill by telephone converted to the formulary (odds ratio [OR], 2.24; 95% confidence interval [CI], 1.02 to 4.72). Patient age (OR, 1.03; CI, 1.01 to 1.05) and male gender (OR, 2.00; CI, 1.09 to 3.67) were each significant correlates of conversion. After adjustment in a multivariable model, only telephone refill request (adjusted OR, 2.31; CI, 1.07 to 4.97) and age (adjusted OR, 1.03; CI, 1.01 to 1.06) remained significant. Among the patients who made a telephone refill request, those who converted were more likely to completely trust their physician's judgment (P=.04) and to trust their physician to put their health over cost concerns (P=.05). Formulary conversion reduced costs beginning 3 months after the conversion date.
  
  
  CONCLUSIONS
  A protocol for encouraging conversion to a unified formulary at the point of a telephone refill request increases formulary compliance rates and reduces medication costs. Patients who decline to convert medications are less likely to trust their physician.
authors.affiliation: Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. gsmetana@bidmc.harvard.edu
authors.forename: Gerald W
authors.initials: GW
authors.lastname: Smetana
authors.forename: Roger B
authors.initials: RB
authors.lastname: Davis
authors.forename: Russell S
authors.initials: RS
authors.lastname: Phillips
mesh_terms: D000328:Adult; D000367:Age Factors; D015331:Cohort Studies; D003365:Costs and Cost Analysis; D005260:Female; D005569:Formularies as Topic / Q000592:standards*; D006801:Humans; D008297:Male; D008329:Managed Care Programs; D015999:Multivariate Analysis; D010361:Patients / Q000523:psychology*; D004364:Pharmaceutical Preparations / Q000191:economics; D010817:Physician-Patient Relations; D011446:Prospective Studies; D011795:Surveys and Questionnaires; D013689:Telephone; D014481:United States
chemical_list: D004364:Pharmaceutical Preparations